Mechanisms and Medicines for Remyelination
Mark Bothwell
Index: 10.1146/annurev-med-050715-104400
Full Text: HTML
Abstract
Demyelination of central nervous system axons, associated with traumatic injury and demyelinating diseases such as multiple sclerosis, causes impaired neural transmission and ultimately axon degeneration. Consequently, extensive research has focused on signaling systems that promote myelinating activity of oligodendrocytes or promote production of new oligodendrocytes from oligodendrocyte progenitor cells. Many receptor systems, notably including growth factor receptors and G protein–coupled receptors, control myelination. A number of recent clinical trials target these receptor signaling pathways.
Latest Articles:
Gene Editing: A New Tool for Viral Disease
2017-01-18
[10.1146/annurev-med-051215-031129]
2017-01-18
[10.1146/annurev-med-050715-104506]
Esophageal Adenocarcinoma: Screening, Surveillance, and Management
2017-01-18
[10.1146/annurev-med-050715-104218]
Management of Rectal Cancer Without Radical Resection
2017-01-18
[10.1146/annurev-med-062915-021419]
The End of Nihilism: Systemic Therapy of Advanced Non–Small Cell Lung Cancer
2017-01-18
[10.1146/annurev-med-042915-102442]